Rajputana Bio.

Who are the top shareholders of the Rajputana Bio.?

The top shareholders of Rajputana Bio include promoter Sudeep Soni with 22.45%, followed by Nine Alps Trust-nine Alps Opportunity Fund at 3.38%, and individual investors holding 24.83%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Rajputana Bio include the promoters, who hold the majority of the shares. The promoter with the highest holding is Sudeep Soni, who owns 22.45% of the company. In terms of public shareholders, the highest is Nine Alps Trust-nine Alps Opportunity Fund, with a holding of 3.38%. Additionally, individual investors collectively hold 24.83% of the shares. There are also two foreign institutional investors (FIIs) that hold a combined 0.48% of the company. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

When is the next results date for Rajputana Bio.?

No Upcoming Board Meetings

Has Rajputana Bio. declared dividend?

No Dividend History Available

Who are the peers of the Rajputana Bio.?

Peers of Rajputana Bio. include Coal India, Doms Industries, Sandur Manganese, and others. Doms Industries leads in 1-year returns at 32.62%, while Rajputana Bio. has a return of 0.00%.

Peers: The peers of Rajputana Bio. are Coal India, Doms Industries, Sandur Manganese, Navneet Educat., Flair Writing, Nidhi Granites, Crayons Advertis, Pramara Promotio, Urban Enviro, Aesthetik.<BR><BR>Quality Snapshot: Excellent management risk is observed at Coal India, Sandur Manganese, and Urban Enviro, while Good management risk is found at Doms Industries, Crayons Advertis, and Aesthetik. Average management risk is present at Navneet Educat., Flair Writing, and Pramara Promotio, while Below Average management risk is seen at Nidhi Granites. Growth is Excellent for Coal India, Doms Industries, Sandur Manganese, Urban Enviro, and Aesthetik, while Average growth is noted at Nidhi Granites and Good growth at Pramara Promotio. Below Average growth is observed at Navneet Educat. and Flair Writing. Capital Structure is Excellent for Coal India, Doms Industries, Sandur Manganese, Flair Writing, Crayons Advertis, and the rest.<BR><BR>Return Snapshot: Doms Industries has the highest 1-year return at 32.62%, while Coal India has the lowest at -23.33%. Rajputana Bio.'s 1-year return is 0.00%, which is lower than Doms Industries and higher than Coal India. Additionally, Nidhi Granites is the only peer with a negative six-month return.

What is the technical trend for Rajputana Bio.?

As of June 2, 2025, Rajputana Bio's technical trend is neutral, showing a shift from mildly bearish to sideways, with no clear signals from key indicators like MACD, KST, and RSI.

As of 2 June 2025, the technical trend for Rajputana Bio has changed from mildly bearish to sideways. The weekly MACD and KST show no clear signals, while the monthly indicators are also lacking definitive trends. The RSI on the weekly timeframe indicates no signal, and the Dow Theory suggests a mildly bearish stance on the weekly chart. The Bollinger Bands are indicating a sideways movement on both weekly and monthly timeframes. Overall, the current technical stance is neutral, reflecting a lack of strong directional momentum.

What does Rajputana Bio. do?

Rajputana Biodiesel Limited, a micro-cap company incorporated in 2016, operates in the biodiesel sector and recently transitioned to a public company. It has a market cap of INR 156 Cr, with key metrics including a P/E ratio of 27.00 and a return on equity of 42.02%.

Overview: <BR>Rajputana Biodiesel Limited operates in the miscellaneous industry as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in 2016 under the name Rajputana Biodiesel Systems Private Limited. It later converted from a Private Limited Company to a Public Limited Company, adopting the name Rajputana Biodiesel Limited, with a fresh Certificate of Incorporation issued on July 8, 2024. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 156 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 27.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.08 <BR>Return on Equity: 42.02% <BR>Price-to-Book: 11.01 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Rajputana Bio.?

As of 24th July, Rajputana Biodiesel Ltd has a market capitalization of 156.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 14.22 Cr and Total Assets of 42.30 Cr; however, there is no valid financial data available for net sales or net profit for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Rajputana Biodiesel Ltd has a market capitalization of 156.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for net sales or net profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 14.22 Cr and Total Assets valued at 42.30 Cr.

Is Rajputana Bio. overvalued or undervalued?

As of August 28, 2025, Rajputana Bio. is considered very expensive and overvalued with a high PE ratio of 30.61, a Price to Book Value of 12.86, and an EV to EBITDA of 22.18, despite a recent 16.38% return, it has underperformed year-to-date with a 16.97% decline compared to the Sensex's 3.62% gain.

As of 28 August 2025, Rajputana Bio. has moved from a fair valuation to very expensive. The company is currently overvalued, as indicated by its high PE ratio of 30.61, a Price to Book Value of 12.86, and an EV to EBITDA of 22.18. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Rajputana Bio.'s PE ratio is significantly lower than Solar Industries, which has a PE of 99.06, but higher than Godrej Industries, which stands at 41.86. Additionally, the PEG ratio of Rajputana Bio. is 0.00, indicating no growth relative to its price, which further supports the conclusion of overvaluation. Notably, while Rajputana Bio. has experienced a 16.38% return over the past month, it has underperformed on a year-to-date basis, down 16.97%, contrasting with the Sensex's 3.62% gain.

How has been the historical performance of Rajputana Bio.?

Rajputana Bio's historical performance shows growth in net sales and profits, with net sales increasing to 67.31 crore and profit after tax rising to 5.92 crore for the fiscal year ending March 2025. However, cash flow from operating activities was negative at -15.00 crore, indicating challenges in cash flow management.

Answer:<BR>The historical performance of Rajputana Bio shows a positive trend in key financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Rajputana Bio reported net sales of 67.31 crore, an increase from 53.46 crore in March 2024. The total operating income also rose to 67.31 crore from 53.46 crore, while total expenditure increased to 58.37 crore from 45.75 crore. This resulted in an operating profit (PBDIT) of 10.23 crore, up from 7.93 crore the previous year. Profit before tax improved to 7.53 crore from 6.14 crore, leading to a profit after tax of 5.92 crore, compared to 4.56 crore in the prior year. The company’s earnings per share slightly decreased to 8.42 from 8.89, while the PAT margin improved to 8.8% from 8.53%. On the balance sheet, total assets grew to 60.49 crore from 42.30 crore, with total liabilities also increasing to 60.49 crore from 42.30 crore. Cash flow from operating activities showed a negative trend at -15.00 crore, though financing activities provided a net inflow of 15.00 crore. Overall, Rajputana Bio's financial performance indicates growth in sales and profits, despite challenges in cash flow management.

Why is Rajputana Biodiesel Ltd falling/rising?

As of 18-Jan, Rajputana Biodiesel Ltd's stock price is stable at 249.95, with a recent 4.15% increase over the past week, outperforming the Sensex. However, it has declined 18.44% over the past year, indicating mixed signals regarding its long-term momentum.

As of 18-Jan, Rajputana Biodiesel Ltd's stock price is currently stable at 249.95, showing no change from the previous trading session. However, the stock has demonstrated a positive trend over the past week, with a rise of 4.15%, significantly outperforming the Sensex, which only increased by 0.04% during the same period. This recent performance indicates a growing interest among investors, as evidenced by a notable increase in delivery volume, which rose by 163.16% compared to the 5-day average.<BR><BR>Despite the positive short-term performance, the stock has faced challenges over longer periods, with a decline of 18.44% over the past year, contrasting sharply with the Sensex's gain of 10.22%. Additionally, while the stock is currently above its 5-day, 20-day, and 200-day moving averages, it remains below its 50-day and 100-day moving averages, suggesting mixed signals regarding its longer-term momentum.<BR><BR>Overall, the stock's recent rise can be attributed to increased investor participation and short-term outperformance against the sector, despite the longer-term declines.

Which are the latest news on Rajputana Bio.?